van Asperen CJ - Search Results

1

An association between cartilaginous tumours and breast cancer in the national pathology registration in The Netherlands points towards a possible genetic trait.

Odink AE, van Asperen CJ, Vandenbroucke JP, Cleton-Jansen AM, Hogendoorn PC. Odink AE, et al. Among authors: van asperen cj. J Pathol. 2001 Feb;193(2):190-2. doi: 10.1002/1096-9896(2000)9999:9999<::AID-PATH781>3.0.CO;2-V. J Pathol. 2001. PMID: 11180165

2

Multiple primary malignancies in osteosarcoma patients. Incidence and predictive value of osteosarcoma subtype for cancer syndromes related with osteosarcoma.

Hauben EI, Arends J, Vandenbroucke JP, van Asperen CJ, Van Marck E, Hogendoorn PC. Hauben EI, et al. Among authors: van asperen cj, van marck e. Eur J Hum Genet. 2003 Aug;11(8):611-8. doi: 10.1038/sj.ejhg.5201012. Eur J Hum Genet. 2003. PMID: 12891382

3

Possible consequences of applying guidelines to healthy women with a family history of breast cancer.

van Asperen CJ, Tollenaar RA, Krol-Warmerdam EM, Blom J, Hoogendoorn WE, Seynaeve CM, Brekelmans CT, Devilee P, Cornelisse CJ, Klijn JG, de Bock GH. van Asperen CJ, et al. Eur J Hum Genet. 2003 Aug;11(8):633-6. doi: 10.1038/sj.ejhg.5201021. Eur J Hum Genet. 2003. PMID: 12891386

4

Causality and functional relevance of BRCA1 and BRCA2 pathogenic variants in non-high-grade serous ovarian carcinomas.

Kramer C, Lanjouw L, Ruano D, Ter Elst A, Santandrea G, Solleveld-Westerink N, Werner N, van der Hout AH, de Kroon CD, van Wezel T, Berger L, Jalving M, Wesseling J, Smit V, de Bock GH, van Asperen CJ, Mourits M, Vreeswijk M, Bart J, Bosse T. Kramer C, et al. Among authors: van asperen cj. J Pathol. 2024 Feb;262(2):137-146. doi: 10.1002/path.6218. Epub 2023 Oct 18. J Pathol. 2024. PMID: 37850614

5

How women with a family history of breast cancer and their general practitioners act on genetic advice in general practice: prospective longitudinal study.

de Bock GH, van Asperen CJ, de Vries JM, Hageman GC, Springer MP, Kievit J. de Bock GH, et al. Among authors: van asperen cj. BMJ. 2001 Jan 6;322(7277):26-7. doi: 10.1136/bmj.322.7277.26. BMJ. 2001. PMID: 11141149 Free PMC article. No abstract available.

6

[Screening for breast cancer on basis of individual risk assessment for women ineligible for the national population screening program].

van Asperen CJ, de Bock GH, van der Horst F, de Koning HJ, Rutgers EJ. van Asperen CJ, et al. Among authors: van der horst f. Ned Tijdschr Geneeskd. 2001 Jan 20;145(3):120-5. Ned Tijdschr Geneeskd. 2001. PMID: 11206121 Review. Dutch.

7

Genetic counselling and the intention to undergo prophylactic mastectomy: effects of a breast cancer risk assessment.

van Dijk S, Otten W, Zoeteweij MW, Timmermans DR, van Asperen CJ, Breuning MH, Tollenaar RA, Kievit J. van Dijk S, et al. Among authors: van asperen cj. Br J Cancer. 2003 Jun 2;88(11):1675-81. doi: 10.1038/sj.bjc.6600988. Br J Cancer. 2003. PMID: 12771979 Free PMC article.

8

Tumour characteristics and prognosis of breast cancer patients carrying the germline CHEK2*1100delC variant.

de Bock GH, Schutte M, Krol-Warmerdam EM, Seynaeve C, Blom J, Brekelmans CT, Meijers-Heijboer H, van Asperen CJ, Cornelisse CJ, Devilee P, Tollenaar RA, Klijn JG. de Bock GH, et al. Among authors: van asperen cj. J Med Genet. 2004 Oct;41(10):731-5. doi: 10.1136/jmg.2004.019737. J Med Genet. 2004. PMID: 15466005 Free PMC article.

9

Risk reduction of contralateral breast cancer and survival after contralateral prophylactic mastectomy in BRCA1 or BRCA2 mutation carriers.

van Sprundel TC, Schmidt MK, Rookus MA, Brohet R, van Asperen CJ, Rutgers EJ, Van't Veer LJ, Tollenaar RA. van Sprundel TC, et al. Among authors: van asperen cj, van t veer lj. Br J Cancer. 2005 Aug 8;93(3):287-92. doi: 10.1038/sj.bjc.6602703. Br J Cancer. 2005. PMID: 16052221 Free PMC article.

10

Association between the CHEK2*1100delC germ line mutation and estrogen receptor status.

de Bock GH, Mourits MJ, Schutte M, Krol-Warmerdam EM, Seynaeve C, Blom J, Brekelmans CT, Meijers-Heijboer H, van Asperen CJ, Cornelisse CJ, Devilee P, Tollenaar RA, Klijn JG. de Bock GH, et al. Among authors: van asperen cj. Int J Gynecol Cancer. 2006;16 Suppl 2:552-5. doi: 10.1111/j.1525-1438.2006.00694.x. Int J Gynecol Cancer. 2006. PMID: 17010071

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

225 results

Search Page

Filters